Quinoxaline compounds
US7304051B2 · kind B2 · utility
3Cited by
2References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2004 |
| Grant date | Dec 4, 2007 |
| Priority date | — |
| Expiry date | May 25, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Amidophenyl-sulfonylamino-quinoxaline compounds of formula (I)are CCK2 modulators useful in the treatment of CCK2 mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.